The authors showed that both total amount of infused insulin and glycemic control were associated with lower mortality (independently of age, delayed ICU admission, Acute Physiology and Chronic Health Evaluation II score, reason for ICU admission, history of malignancy or diabetes, and at-admission hyperglycemia). This evidence concerns the gene INS and Hyperglycemia.